Expressed in somatic primodium at L2 stage. Expressed in VU/DU and AC at L3 stage. Expressed in uterine epithelium and spermathecal epithelium at L4 stage.
Expressed in somatic primodium at L2 stage. Expressed in VU/DU and AC at L3 stage. Expressed in uterine epithelium and spermathecal epithelium at L4 stage.
Expressed in somatic primodium at L2 stage. Expressed in VU/DU, AC and DTC at L3 stage. Expressed in uterine epithelium and spermathecal epithelium at L4 stage.
Expressed in somatic primodium at L2 stage. Expressed in spermathecal/sheath lineage and VU/DU at L3 stage. Expressed in uterine epithelium and spermathecal epithelium at L4 stage.
Expressed in Z1/Z4 at L1 stage. Expressed in spermathecal/sheath lineage, VU/DU, AC and DTC at L3 stage. Expressed in uterine epithelium and spermathecal epithelium at L4 stage.
Expressed in Z1/Z4 at L1 stage. Expressed in somatic primodium at L2 stage. Expressed in VU/DU, AC and DTC at L3 stage. Expressed in uterine epithelium and spermathecal epithelium at L4 stage.
ayIs9 expresses GFP in a subset of cells within the somatic gonad. These GFP cells are the dorsal uterine (DU) cells based on their positions and division patterns. Furthermore, GFP expression was abolished in all animals in which the DUs were ablated (n=10), but could always be observed in control animals in which the DUs were left intact (n=25). Based on these results, EGL-17 appears to be expressed in the somatic gonad by the DU cells.